Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis
Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. W...
Saved in:
| Published in | PloS one Vol. 9; no. 5; p. e89952 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article Web Resource |
| Language | English |
| Published |
United States
Public Library of Science
12.05.2014
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0089952 |
Cover
| Abstract | Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk.
We investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998-2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously.
Based on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value≤0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value≥0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95%CI 1.05-1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation.
We found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies. |
|---|---|
| AbstractList | Introduction Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk. Material and Methods We investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998-2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously. Results Based on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value[less than or equal to]0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value[greater than or equal to]0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95%CI 1.05-1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation. Discussion We found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies. Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk.INTRODUCTIONGermline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk.We investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998-2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously.MATERIAL AND METHODSWe investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998-2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously.Based on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value≤0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value≥0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95%CI 1.05-1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation.RESULTSBased on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value≤0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value≥0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95%CI 1.05-1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation.We found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies.DISCUSSIONWe found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies. Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk. We investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998-2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously. Based on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value[less than or equal to]0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value[greater than or equal to]0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95%CI 1.05-1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation. We found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies. Introduction: Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk. Material and Methods: We investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998–2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously. Results: Based on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value≤0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value≥0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95%CI 1.05–1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation. Discussion: We found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies. This work was supported by the Fondo de Investigación Sanitaria, Spain (grant numbers 00/0745, PI051436, PI061614, G03/174); Red Temá tica de Investigación Cooperativa en Cáncer (grant number RD06/0020-RTICC), Spain; Marató TV3 (grant number 050830); European Commission (grant numbers EU-FP7-HEALTH-F2-2008-201663-UROMOL; US National Institutes of Health (grant number USA-NIH-RO1-CA089715); and the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute at the National Institutes of Health, USA; Consolider ONCOBIO (Ministerio de Economía y Competitividad, Madrid, Spain). Introduction Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk. Material and Methods We investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998–2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously. Results Based on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value≤0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value≥0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95%CI 1.05–1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation. Discussion We found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies. Introduction Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk. Material and Methods We investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998–2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously. Results Based on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value≤0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value≥0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95%CI 1.05–1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation. Discussion We found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies. Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk. We investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998-2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously. Based on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value≤0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value≥0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95%CI 1.05-1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation. We found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies. Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variants in the TP53 pathway and bladder cancer risk.We investigated 184 tagSNPs from 18 genes in 1,058 cases and 1,138 controls from the Spanish Bladder Cancer/EPICURO Study. Cases were newly-diagnosed bladder cancer patients during 1998-2001. Hospital controls were age-gender, and area matched to cases. SNPs were genotyped in blood DNA using Illumina Golden Gate and TaqMan assays. Cases were subphenotyped according to stage/grade and tumor p53 expression. We applied classical tests to assess individual SNP associations and the Least Absolute Shrinkage and Selection Operator (LASSO)-penalized logistic regression analysis to assess multiple SNPs simultaneously.Based on classical analyses, SNPs in BAK1 (1), IGF1R (5), P53AIP1 (1), PMAIP1 (2), SERINPB5 (3), TP63 (3), and TP73 (1) showed significant associations at p-value≤0.05. However, no evidence of association, either with overall risk or with specific disease subtypes, was observed after correction for multiple testing (p-value≥0.8). LASSO selected the SNP rs6567355 in SERPINB5 with 83% of reproducibility. This SNP provided an OR = 1.21, 95%CI 1.05-1.38, p-value = 0.006, and a corrected p-value = 0.5 when controlling for over-estimation.We found no strong evidence that common variants in the TP53 pathway are associated with bladder cancer susceptibility. Our study suggests that it is unlikely that TP53 Arg72Pro is implicated in the UCB in white Europeans. SERPINB5 and TP63 variation deserve further exploration in extended studies. |
| Audience | Academic |
| Author | García-Closas, Montserrat Calle, M. Luz Márquez, Mirari Silverman, Debra T. Real, Francisco X. Lloreta, Josep Pineda, Silvia Kogevinas, Manolis Herranz, Jesús Tardón, Adonina Navarro, Arcadi Milne, Roger L. Chanock, Stephen J. González-Neira, Anna Carrato, Alfredo López de Maturana, Evangelina Baum, Erin Rothman, Nathaniel Guey, Lin T. Malats, Núria |
| AuthorAffiliation | 1 Spanish National Cancer Research Center (CNIO), Madrid, Spain 8 Servicio de Oncología, Hospital Universitario de Elche, Elche, Spain 2 Systems Biology Department, University of Vic, Vic, Spain 11 Institut de Biologia Evolutiva (UPF-CSIC), Barcelona, Spain 9 Servicio de Oncología, Hospital Universitario Ramon y Cajal, Madrid, Spain 4 Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain National Cancer Center, Japan 3 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America 10 Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain 5 Institut Municipal d'Investigació Mèdica – Hospital del Mar, Barcelona, Spain 7 Departament de Patologia, Hospital del Mar – IMAS, Barcelona, Spain 6 Department of Preventive Medicine, Universidad de Oviedo, Oviedo, Spain 13 Instituto Nacional de Bioinformática, Barcelona, Spain 12 Institució Catalana de Re |
| AuthorAffiliation_xml | – name: 8 Servicio de Oncología, Hospital Universitario de Elche, Elche, Spain – name: 2 Systems Biology Department, University of Vic, Vic, Spain – name: 3 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland, United States of America – name: 13 Instituto Nacional de Bioinformática, Barcelona, Spain – name: 9 Servicio de Oncología, Hospital Universitario Ramon y Cajal, Madrid, Spain – name: 12 Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain – name: 10 Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain – name: 1 Spanish National Cancer Research Center (CNIO), Madrid, Spain – name: 11 Institut de Biologia Evolutiva (UPF-CSIC), Barcelona, Spain – name: 6 Department of Preventive Medicine, Universidad de Oviedo, Oviedo, Spain – name: National Cancer Center, Japan – name: 7 Departament de Patologia, Hospital del Mar – IMAS, Barcelona, Spain – name: 5 Institut Municipal d'Investigació Mèdica – Hospital del Mar, Barcelona, Spain – name: 4 Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain |
| Author_xml | – sequence: 1 givenname: Silvia surname: Pineda fullname: Pineda, Silvia – sequence: 2 givenname: Roger L. surname: Milne fullname: Milne, Roger L. – sequence: 3 givenname: M. Luz surname: Calle fullname: Calle, M. Luz – sequence: 4 givenname: Nathaniel surname: Rothman fullname: Rothman, Nathaniel – sequence: 5 givenname: Evangelina surname: López de Maturana fullname: López de Maturana, Evangelina – sequence: 6 givenname: Jesús surname: Herranz fullname: Herranz, Jesús – sequence: 7 givenname: Manolis surname: Kogevinas fullname: Kogevinas, Manolis – sequence: 8 givenname: Stephen J. surname: Chanock fullname: Chanock, Stephen J. – sequence: 9 givenname: Adonina surname: Tardón fullname: Tardón, Adonina – sequence: 10 givenname: Mirari surname: Márquez fullname: Márquez, Mirari – sequence: 11 givenname: Lin T. surname: Guey fullname: Guey, Lin T. – sequence: 12 givenname: Montserrat surname: García-Closas fullname: García-Closas, Montserrat – sequence: 13 givenname: Josep surname: Lloreta fullname: Lloreta, Josep – sequence: 14 givenname: Erin surname: Baum fullname: Baum, Erin – sequence: 15 givenname: Anna surname: González-Neira fullname: González-Neira, Anna – sequence: 16 givenname: Alfredo surname: Carrato fullname: Carrato, Alfredo – sequence: 17 givenname: Arcadi surname: Navarro fullname: Navarro, Arcadi – sequence: 18 givenname: Debra T. surname: Silverman fullname: Silverman, Debra T. – sequence: 19 givenname: Francisco X. surname: Real fullname: Real, Francisco X. – sequence: 20 givenname: Núria surname: Malats fullname: Malats, Núria |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24818791$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk11v0zAUhiM0xD7gHyCIhITgosVfcZxdIJUKxqRJm8YYl5bjnLQerl3sZLB_j9tm0zpNCEWRnZPnPT5-7bOf7TjvIMteYjTGtMQfrnwfnLLjZQqPERJVVZAn2R6uKBlxgujOvfluth_jFUIFFZw_y3YJE1iUFd7LfhyBg87o_FIFozrjXW5c3s0hvzgraH6muvlvdZMr1-SfrGoaCPlUOZ2GcxN_jvNJPvWLZYA5uGiuIZ-kkm6iic-zp62yEV4M40H2_cvni-nX0cnp0fF0cjLSZSm6kaAlFULQigAI4LioqdClopqDFpTzmnOMeKMrqFvCuKpRyxrSqKKugKQIPcheb_IurY9y8CRKXBAqSsxokYjjDdF4dSWXwSxUuJFeGbkO-DCTKiQHLEhNUEvrAmlRtaxsuVJc10yXDHNaMNqkXB-H1fp6AY0G1wVlt5Ju_3FmLmf-WjKEBWU8JaCbBNbADNLitZHXZC1cz3ubqtGyBkkIFxILhAhJKrxR6dhrGSDZr1W3Vt19rF6CSiIpLhgpk-bdUGrwv3qInVyYqMFa5cD3a4cYZRSVVULfPEAf93GgZipZZVzr0w71KqmcMCyKglQIJWr8CJWeBhZGp6vamhTfErzfEiSmgz_dTPUxyuNv5__Pnl5us2_vsXNQtptHb_vVFY_b4Kv7Z3p3mLc9koDDwf3gYwzQSm26daukrRkrMZKrhrw1Ta4aUg4NmcTsgfg2_z9lfwGEiDZj |
| CitedBy_id | crossref_primary_10_1186_s12920_022_01372_z crossref_primary_10_1002_gcc_22528 crossref_primary_10_1016_j_neubiorev_2018_06_013 crossref_primary_10_1007_s12094_020_02476_7 crossref_primary_10_3390_cancers14030699 crossref_primary_10_3389_fmolb_2020_00012 crossref_primary_10_1016_j_gene_2021_145989 crossref_primary_10_7124_FEEO_v23_1017 crossref_primary_10_1371_journal_pgen_1005689 crossref_primary_10_1016_j_gene_2025_149259 crossref_primary_10_3389_fmolb_2016_00035 crossref_primary_10_1002_mc_22543 crossref_primary_10_1016_j_gpb_2015_04_001 |
| Cites_doi | 10.1002/ijc.22833 10.1086/521987 10.1158/1055-9965.EPI-06-0021 10.1016/j.urolonc.2011.11.031 10.1038/nrc2584 10.1038/ng.229 10.1016/j.eururo.2009.08.001 10.1093/bioinformatics/btp041 10.1007/s12094-007-0003-x 10.1111/j.2517-6161.1996.tb02080.x 10.1007/s10549-009-0480-4 10.1093/mutage/ger067 10.1214/aos/1176344552 10.1097/00000478-199812000-00001 10.1007/s11033-012-1674-0 10.1038/sj.onc.1209228 10.1038/nrg3118 10.1016/j.urology.2010.04.044 10.1056/NEJM200007133430201 10.1080/03008880802285172 10.1056/NEJM199703063361018 10.1093/bioinformatics/btq448 10.1038/nrg1155 10.1016/S1470-2045(09)70187-1 10.1002/ijc.24603 10.1016/j.gene.2012.09.085 10.1038/nrc1697 10.1504/IJDMB.2012.049249 10.1038/ng.687 10.1126/science.1978757 10.1016/S1470-2045(07)70008-6 10.1007/s00408-013-9461-9 10.1053/j.seminoncol.2012.08.008 10.1002/bimj.200900028 |
| ContentType | Journal Article Web Resource |
| Copyright | COPYRIGHT 2014 Public Library of Science 2014 Pineda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2014 Pineda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. info:eu-repo/semantics/openAccess 2014 Pineda et al 2014 Pineda et al |
| Copyright_xml | – notice: COPYRIGHT 2014 Public Library of Science – notice: 2014 Pineda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2014 Pineda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. info:eu-repo/semantics/openAccess – notice: 2014 Pineda et al 2014 Pineda et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 XX2 Q33 5PM DOA |
| DOI | 10.1371/journal.pone.0089952 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest SciTech Premium Collection Technology Collection Materials Science & Engineering Database ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest SciTech Premium Collection Technology Collection Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic Recercat Université de Liège - Open Repository and Bibliography (ORBI) PubMed Central (Full Participant titles) DOAJ - The Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Agricultural Science Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | TP53 Pathway and Bladder Cancer Susceptibility |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1523871435 oai_doaj_org_article_c20f3b50c89f47f6aa6cb4c74163543d PMC4018346 oai_orbi_ulg_ac_be_2268_180022 oai_recercat_cat_2072_315427 3301248151 A418552900 24818791 10_1371_journal_pone_0089952 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States--US Maryland Spain |
| GeographicLocations_xml | – name: Maryland – name: Spain – name: United States--US |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA089715 – fundername: NCI NIH HHS grantid: R01-CA089715 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM 3V. BBORY CGR CUY CVF ECM EIF IPNFZ NPM PV9 RIG RZL PMFND 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 ESTFP PUEGO XX2 Q33 5PM - 02 AAPBV ABPTK ADACO BBAFP KM |
| ID | FETCH-LOGICAL-c778t-8373888392ee8e615b38c7a3c6ec8366b66106dc9ebf246ab0f4d2da5b9e2f243 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Fri Nov 26 17:13:04 EST 2021 Wed Aug 27 01:27:53 EDT 2025 Thu Aug 21 18:14:24 EDT 2025 Fri Jul 25 15:30:15 EDT 2025 Fri Sep 26 12:50:05 EDT 2025 Fri Sep 05 14:40:58 EDT 2025 Fri Jul 25 10:32:50 EDT 2025 Tue Jun 17 20:45:37 EDT 2025 Tue Jun 10 20:40:10 EDT 2025 Fri Jun 27 04:52:02 EDT 2025 Fri Jun 27 03:44:49 EDT 2025 Thu May 22 21:22:16 EDT 2025 Wed Feb 19 02:30:02 EST 2025 Tue Jul 01 03:10:11 EDT 2025 Thu Apr 24 22:56:35 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c778t-8373888392ee8e615b38c7a3c6ec8366b66106dc9ebf246ab0f4d2da5b9e2f243 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 scopus-id:2-s2.0-84901275033 Competing Interests: FX Real is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Conceived and designed the experiments: SP RLM NR MK DTS FXR NM. Performed the experiments: SJC JL AGN. Analyzed the data: SP RLM MLC ELdM JH LTG EB. Contributed reagents/materials/analysis tools: AN AC AT MM DTS NR MK MGC FXR NM. Wrote the paper: SP RLM NM. |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0089952 |
| PMID | 24818791 |
| PQID | 1523871435 |
| PQPubID | 1436336 |
| ParticipantIDs | plos_journals_1523871435 doaj_primary_oai_doaj_org_article_c20f3b50c89f47f6aa6cb4c74163543d pubmedcentral_primary_oai_pubmedcentral_nih_gov_4018346 liege_orbi_v2_oai_orbi_ulg_ac_be_2268_180022 csuc_recercat_oai_recercat_cat_2072_315427 proquest_miscellaneous_1524343079 proquest_journals_1523871435 gale_infotracmisc_A418552900 gale_infotracacademiconefile_A418552900 gale_incontextgauss_ISR_A418552900 gale_incontextgauss_IOV_A418552900 gale_healthsolutions_A418552900 pubmed_primary_24818791 crossref_citationtrail_10_1371_journal_pone_0089952 crossref_primary_10_1371_journal_pone_0089952 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-05-12 |
| PublicationDateYYYYMMDD | 2014-05-12 |
| PublicationDate_xml | – month: 05 year: 2014 text: 2014-05-12 day: 12 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2014 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | JJ Goeman (ref25) 2010; 52 AP Mitra (ref9) 2012; 39 D Malkin (ref10) 1997; 336 Q Qiao (ref16) 2013; 191 D Malkin (ref11) 1990; 250 B Efron (ref24) 1979; 7 C Whibley (ref12) 2009; 9 ref1 LT Guey (ref7) 2010; 57 SJ Klug (ref14) 2009; 10 C Samanic (ref2) 2006; 15 XR Wu (ref6) 2005; 5 LA Kiemeney (ref30) 2008; 40 ZNS Yang (ref17) 2013; 512 J Friedman (ref23) 2001; 533 KJ Liu (ref15) 2012; 39 NM Luis (ref5) 2007; 9 A Naccarati (ref28) 2012; 27 G Gibson (ref32) 2011; 13 H Zhou (ref35) 2010; 26 N Malats (ref3) 2008; Suppl R Tibshirani (ref22) 1996; 58 JI Epstein (ref19) 1998; 22 L Yan (ref27) 2009; 125 N Rothman (ref4) 2010; 42 P Lichtenstein (ref31) 2000; 343 FX Real (ref8) 2007; 8 B Lorente-Galdos (ref20) 2012; 6 SR Browning (ref21) 2007; 81 DK Jiang (ref13) 2010; 76 HY Lin (ref29) 2013; 31 TT Wu (ref34) 2009; 25 JP Louhelainen (ref36) 2006; 25 Z Zhang (ref18) 2009; 120 J Hoh (ref33) 2003; 4 Y Zhou (ref26) 2007; 121 |
| References_xml | – volume: 121 start-page: 1481 year: 2007 ident: ref26 article-title: P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature publication-title: Int J Cancer doi: 10.1002/ijc.22833 – ident: ref1 – volume: 81 start-page: 1084 year: 2007 ident: ref21 article-title: Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering publication-title: Am J Hum Genet doi: 10.1086/521987 – volume: 15 start-page: 1348 year: 2006 ident: ref2 article-title: Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-06-0021 – volume: 31 start-page: 1231 year: 2013 ident: ref29 article-title: Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis publication-title: Urol Oncol doi: 10.1016/j.urolonc.2011.11.031 – volume: 9 start-page: 95 year: 2009 ident: ref12 article-title: p53 polymorphisms: cancer implications publication-title: Nat Rev Cancer doi: 10.1038/nrc2584 – volume: 40 start-page: 1307 year: 2008 ident: ref30 article-title: Sequence variant on 8q24 confers susceptibility to urinary bladder cancer publication-title: Nat Genet doi: 10.1038/ng.229 – volume: 57 start-page: 283 year: 2010 ident: ref7 article-title: Genetic susceptibility to distinct bladder cancer subphenotypes publication-title: Eur Urol doi: 10.1016/j.eururo.2009.08.001 – volume: 25 start-page: 714 year: 2009 ident: ref34 article-title: Genome-wide association analysis by lasso penalized logistic regression publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp041 – volume: 9 start-page: 5 year: 2007 ident: ref5 article-title: Molecular biology of bladder cancer publication-title: Clin Transl Oncol doi: 10.1007/s12094-007-0003-x – volume: 58 start-page: 267 year: 1996 ident: ref22 article-title: Regression Shrinkage and Selection via the Lasso publication-title: Journal of the Royal Statistical Society Series B (Methodological) doi: 10.1111/j.2517-6161.1996.tb02080.x – volume: 533 start-page: 214 year: 2001 ident: ref23 article-title: The Elements of statistical learning: Data mining, inference and prediction publication-title: Springer Series in Statistics – volume: 120 start-page: 509 year: 2009 ident: ref18 article-title: P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-009-0480-4 – volume: 27 start-page: 211 year: 2012 ident: ref28 article-title: Mutations and polymorphisms in TP53 gene–an overview on the role in colorectal cancer publication-title: Mutagenesis doi: 10.1093/mutage/ger067 – volume: 7 start-page: 1 year: 1979 ident: ref24 article-title: Bootstrap Methods: Another Look at the Jackknife publication-title: Annals of Statistics doi: 10.1214/aos/1176344552 – volume: 22 start-page: 1435 year: 1998 ident: ref19 article-title: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee publication-title: Am J Surg Pathol doi: 10.1097/00000478-199812000-00001 – volume: 39 start-page: 8265 year: 2012 ident: ref15 article-title: An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk publication-title: Mol Biol Rep doi: 10.1007/s11033-012-1674-0 – volume: 25 start-page: 2409 year: 2006 ident: ref36 article-title: DBC1 re-expression alters the expression of multiple components of the plasminogen pathway publication-title: Oncogene doi: 10.1038/sj.onc.1209228 – volume: 13 start-page: 135 year: 2011 ident: ref32 article-title: Rare and common variants: twenty arguments publication-title: Nat Rev Genet doi: 10.1038/nrg3118 – volume: 76 start-page: 765 e761 year: 2010 ident: ref13 article-title: Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk publication-title: Urology doi: 10.1016/j.urology.2010.04.044 – volume: 343 start-page: 78 year: 2000 ident: ref31 article-title: Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland publication-title: N Engl J Med doi: 10.1056/NEJM200007133430201 – volume: Suppl start-page: 131 year: 2008 ident: ref3 article-title: Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression publication-title: Scand J Urol Nephrol doi: 10.1080/03008880802285172 – volume: 336 start-page: 734 year: 1997 ident: ref10 article-title: Germ-line mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms publication-title: N Engl J Med doi: 10.1056/NEJM199703063361018 – volume: 26 start-page: 2375 year: 2010 ident: ref35 article-title: Association screening of common and rare genetic variants by penalized regression publication-title: Bioinformatics doi: 10.1093/bioinformatics/btq448 – volume: 4 start-page: 701 year: 2003 ident: ref33 article-title: Mathematical multi-locus approaches to localizing complex human trait genes publication-title: Nat Rev Genet doi: 10.1038/nrg1155 – volume: 10 start-page: 772 year: 2009 ident: ref14 article-title: TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies publication-title: Lancet Oncol doi: 10.1016/S1470-2045(09)70187-1 – volume: 125 start-page: 2903 year: 2009 ident: ref27 article-title: TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis publication-title: Int J Cancer doi: 10.1002/ijc.24603 – volume: 512 start-page: 408 year: 2013 ident: ref17 article-title: Association of p53 Arg72Pro polymorphism with bladder cancer: a meta-analysis publication-title: Gene doi: 10.1016/j.gene.2012.09.085 – volume: 5 start-page: 713 year: 2005 ident: ref6 article-title: Urothelial tumorigenesis: a tale of divergent pathways publication-title: Nat Rev Cancer doi: 10.1038/nrc1697 – volume: 6 start-page: 324 year: 2012 ident: ref20 article-title: Select your SNPs (SYSNPs): a web tool for automatic and massive selection of SNPs publication-title: Int J Data Min Bioinform doi: 10.1504/IJDMB.2012.049249 – volume: 42 start-page: 978 year: 2010 ident: ref4 article-title: A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci publication-title: Nat Genet doi: 10.1038/ng.687 – volume: 250 start-page: 1233 year: 1990 ident: ref11 article-title: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms publication-title: Science doi: 10.1126/science.1978757 – volume: 8 start-page: 91 year: 2007 ident: ref8 article-title: Bladder cancer and apoptosis: matters of life and death publication-title: Lancet Oncol doi: 10.1016/S1470-2045(07)70008-6 – volume: 191 start-page: 369 year: 2013 ident: ref16 article-title: The Association Between TP53 Arg72Pro Polymorphism and Lung Cancer Susceptibility: Evidence from 30,038 Subjects publication-title: Lung doi: 10.1007/s00408-013-9461-9 – volume: 39 start-page: 524 year: 2012 ident: ref9 article-title: Prognostic value of cell-cycle regulation biomarkers in bladder cancer publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2012.08.008 – volume: 52 start-page: 70 year: 2010 ident: ref25 article-title: L1 penalized estimation in the Cox proportional hazards model publication-title: Biom J doi: 10.1002/bimj.200900028 |
| RestrictionsOnAccess | open access |
| SSID | ssj0053866 |
| Score | 2.233272 |
| Snippet | Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer... Introduction Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53... Introduction: Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53... Introduction Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53... |
| SourceID | plos doaj pubmedcentral liege csuc proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e89952 |
| SubjectTerms | Adult Aged Aged, 80 and over Bioinformatics Biology and Life Sciences Bladder Bladder cancer Breast cancer Cancer Cell cycle Deoxyribonucleic acid DNA Epidemiology Female Genes Genetic aspects Genetic diversity Genetic Predisposition to Disease - genetics Genetic research Genetic Variation - genetics Genetics Genetics & genetic processes Genomes Genotype Genètica Génétique & processus génétiques Haplotypes Health aspects Health risk assessment Health risks Hospitals Humans Life sciences Male Medical prognosis Medical research Medicine and Health Sciences Middle Aged Morphology Mutation p53 Protein Physical Sciences Polimorfisme genètic Polymorphism, Single Nucleotide - genetics Regression analysis Reproducibility Risk analysis Risk assessment Risk factors Sciences du vivant Shrinkage Single nucleotide polymorphisms Single-nucleotide polymorphism Studies Tumor proteins Tumor Suppressor Protein p53 - genetics Tumors Urinary bladder Urinary Bladder Neoplasms - genetics Young Adult |
| SummonAdditionalLinks | – databaseName: DOAJ - The Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQ9sIFUV5NKWAQEg-R1rETOzkWRFWQeAha6M2yHYeutMpWm91W_HtmHG_UoErlwGGlbDz78Lz8WRl_Q8hzg2S3nGephxSZglOIFHuNQlx57JomYInCA86fPsvD4_zjSXFyqdUX1oT19MC94vYcZ42wBXNl1eSqkcZIZ3MXgESRixqzL6vYejPV52CIYinjQTmhsr1ol92zeeuR0LSqCj5aiCauW7lI2z8k540ZPrdG1tPZvLsKgf5dSHlpZTq4TW5FSEn3-6lskhu-vUM2Y9B29GVkln51l_zES5Ci57BDDiah05YCBKRHXwtBsTvxhflNTVtTO8OUtKAOvWJBsQJ9lxqKFegLf9pXvYNgz2hyjxwfvD96d5jGzgqpU6pcpiXyGZWIjbwvPYAaK0qnjHDSu1JIaWHVZrJ2lbcNz6WxrMlrXpvCVp7DHXGfTFrQ5RahJlO2qAHFYb0bjFkAVOAWDfMNq2F3lBCxVrN2kXYcu1_MdHiWpmD70atJo3F0NE5C0uFTZz3txjXyr9GCGlYJv3BmqZE1e3iDL84U1wIAI1cJeYt2Hr4YZcMN8Dsd_U5f53cJeYJeovvjqkOe0PvIBlTwirGEPAsSyLLRYhnPL7PqOv3hy49_EPr-bST0Igo1c9CdM_HoBCgA2btGkjsjScgVbjT8Jvg0zNRO9TkPUw_XqxlM3WnrNeDxUme4jwCtbqHrrzXeaQB7AnbYALHhh9bhcPXw02EY_wNW8rV-vgoyeJiZqSohD_roGQzBc4CPqsoSokZxNbLUeKSdngZO9JzB2pTL7f9h2ofkJsDiHGtEMr5DJsvFyj8C6Lm0j0OW-QP4tH6k priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdG-8ILYnwtMMAgJD5EtsTO5wNC7bRpIFGqso29WbbjbBVVUpIWxH_PXeoEgibgoVIaX9vkznf3c3P-HSHPJJLdMua7BkKkC5OCu9hrFPzKYNc0DikKNzh_mETHp8H78_B8i0zavTBYVtnGxCZQZ6XG_8j3Ic_wBJt1h2-XX13sGoVPV9sWGtK2VsjeNBRj18gQQnLoDchwfDiZztrYDN4dRXYDHY_9fWuvvWVZGCQ6TdOQ9RLUQNdrben8u6A9XODzbGRDXZT1Vcj0zwLL3zLW0U1yw0JNOtrMjW2yZYpbZNs6c01fWMbpl7fJZzwEKXoGK-fGVHReUICG9GQacjoFlPhd_qCyyOh4gaGqogc4Wyo6m9df9uiIYlipzOWmGp62TCd3yOnR4cnBsWs7Lrg6jpOVmyDPUYKYyZjEANhRPNGx5DoyOuFRpCCbe1GmU6NyFkRSeXmQsUyGKjUMzvC7ZFCALncIlX6swgzQHdbBwZgCoAXTJfdM7mWwanIIb9UstKUjx64YC9E8Y4thWbJRk0DjCGsch7jdp5YbOo5_yL9CCwrIHqbSciWQTbt7gy_mxUxwAJIsdsgY7dx9Mco2J8rqQlhHFpp5OVehp5M0D-I8kjLSKtANsA0DnjnkMc4SsdnG2sUPMUKWoJClnueQp40Esm8UWN5zIdd1Ld59PPsPoU-zntBzK5SXoDst7ZYKUACyevUkd3uSEEN0b_h1M6fhTtVcfGPNrTfH6wXcuhbKCMDpifBxfQFa3cGp32q8Fr-cE36odYerh590w3gNWOFXmHLdyOAmZy9OHXJv4z2dIVgAsDJOfYfEPb_qWao_UswvG670wIOcFUT3_35ZD8h1AMIBVoX4bJcMVtXaPASwuVKPbAT5Ce23e5k priority: 102 providerName: ProQuest |
| Title | Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24818791 https://www.proquest.com/docview/1523871435 https://www.proquest.com/docview/1524343079 https://recercat.cat/handle/2072/315427 http://orbi.ulg.ac.be/handle/2268/180022 https://pubmed.ncbi.nlm.nih.gov/PMC4018346 https://doaj.org/article/c20f3b50c89f47f6aa6cb4c74163543d http://dx.doi.org/10.1371/journal.pone.0089952 |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdG-8ILYnwtMIpBSHyIVInz4eQBobZaGUiMqqyjb1biOFtFlI6kBfbfc-d8iKAiEA-N0vjc1mff-ef6_DtCnkZIdsuYbSpwkSYMCsfEXKNgVwqzpjkwReEB5w8n_vHCfb_0lnukydlaK7DcubTDfFKLIhv--Hr1Bgz-tc7awO2m0vBynSukKw1DD5xyX-8YYTCf2-4rgHX7fn2A7k81kR7YDTAJt92Zq3qy3Mqa2b_13_0Mt7aRGDVbl7tA6u-xlr9MXtOb5EaNOumoGib7ZE_lt8h-bdclfV6TT7-4TT7jLUjRM1hE616jq5wCSqSnM8-hMwCM36MrGuUJHWfotQo6wYFT0Pmq_DKkI4oeplAXVWA8bUhP7pDF9Oh0cmzWyRdMyXmwMQOkPAoQPikVKMA9sRNIHjnSVzJwfD-Gid3yExmqOGWuH8VW6iYsibw4VAyeOHdJLwe1HhAa2Tz2EgB6GBIHZTFgLhg5qaVSK4EFlEGcRs1C1szkmCAjE3q7jcMKpVKTwH4SdT8ZxGxrXVbMHH-Rf4k9KGAiUYWMNgKJtds3-GIWZ8IBTMm4QcbYz-0Ho6x-sC7ORW3TQjIrdWLPkkGYujz1o8iXsSs1xvVcJzHIIxwlojrR2roSMULCII-FlmWQJ1oCiThyjPQ5j7ZlKd59PPsHoU_zjtCzWihdg-5kVJ-uAAUgwVdH8rAjCe5Edopf6TENLY1X4hvTTdf32wyaLkWsBED2QNi41ACtHuDQbzReCsCDDizCAYXDFzXmsLv4cVuMvwGD_XK13moZPO9s8dAg9yrraTuiMU2D8I5ddXqqW5KvLjRtumvB9OX69_-75gNyHeCyi7EjNjskvU2xVQ8Bkm7iAbnGlxyuwcTG6_TtgPTHRyez-UD_yTPQXugn2H6NZg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdG9wAviPG1wGAGgfgQ2RI7nw8T2samlm2l6rqxN-M4zlZRpaNpmfbP8bdxlzqBoAl42UOlNL6myd357hzf_Y6QFxLBbhlzbQ0m0gal4Db2GoV5pbFrGgcXhQXOB92gfeR9PPFPFsiPqhYG0yorm1ga6nSs8B35OvgZHmGzbv_9-Tcbu0bh7mrVQkOa1grpRgkxZgo79vTlBSzhio3OB5D3S8Z2dwbbbdt0GbBVGEZTO0JsnwjjBK0jDQ4-4ZEKJVeBVhEPggQ8mBOkKtZJxrxAJk7mpSyVfhJrBmc4XPcGWfTwBUqLLG7tdHv9yheANQkCU7DHQ3fd6Mfa-TjXCKwaxz5rOMSWKmbKtA-oncTiCPfPEX11NC6uioT_TOj8zUPu3iG3TWhLN-e6uEQWdH6XLBnjUdDXBuH6zT3yGQ-Bih7DSr1UDTrMKYSidNDzOe1BVHohL6nMU7o1QtM4oduonRPaHxZf1-gmRTM20Wfz7HtaIavcJ0fXwvsHpJUDL5cJlW6Y-ClEk5h3B2MJBHagnpmjMyeFVZpFeMVmoQz8OXbhGIlyTy-EZdCcTQKFI4xwLGLXvzqfw3_8g_4tSlCAt9ITJacC0bvrL_hhTsgEh8CVhRbZQjnXF0ba8sR4ciqM4RCKORlPfEdFceaFWSBloBJPlYG07_HUIquoJWJeNlvbK7GJqEQ-ix3HIs9LCkT7yDGd6FTOikJ0Ph3_B9Fhv0H0yhBlY-CdkqaEAxiAKGINypUGJdgs1Rh-V-o0PGkyFN9Z-ejl8WwEj65EogWsCyLh4noGuLqMql9xvBC_jAH8UTUdrh5-Vg_jPWBGYa7Hs5IGi6qdMLbIw_nsqQXBPAhjw9i1SNiYVw1JNUfy4VmJze454CO94NHfb2uV3GwPDvbFfqe795jcgiDcw4wUl62Q1nQy008g0J0mT401oeTLdRuwn6rauIY |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VRkJcEOVVQ6ELAvEQbpxd22sfKtRX1FIIUWhLb8t6vW4jIqfECVX_Ir-KGWdtMKqASw-REu_EsWdmv5mJ50HIM4XNbhnruAYg0gWl4C7OGoV9ZXBqGgcThQXOH3rh7qH_7jg4XiA_qloYTKusMLEE6nSs8T_yNtgZHuGw7qCd2bSI_nb37dk3FydI4ZPWapyGsmMW0vWy3Zgt8tg3F-cQzhXre9sg--eMdXcOtnZdO3HA1UJEUzfCPj8R-gzGRAaMfcIjLRTXodERD8MErJkXpjo2Scb8UCVe5qcsVUESGwZHOJz3GmkJsPoQCLY2d3r9QWUXAFnC0BbvcdFpW11ZOxvnBpusxnHAGsZxURczbUcJ1AajNcJn6diJdTQuLvOK_0zu_M1adm-Rm9bNpRtzvVwiCya_TZYskBT0pe12_eoO-YxvgYoeQdReqgkd5hTcUnrQDzjtg4d6ri6oylO6OUKYnNAt1NQJHQyLr2t0gyKkTczpPBOfVl1W7pLDK-H9PbKYAy-XCVUdkQQpeJaYgwdrCTh5oKqZZzIvhYjNIbxis9S2FTpO5BjJ8vmegJBoziaJwpFWOA5x62-dzVuB_IP-NUpQguUyE62mEjt51x_wxTzBJAcnlgmHbKKc6xMjbXlgPDmRFkSkZl7Gk8DTUZz5IguVCnXi69KpDnyeOmQVtUTOS2hr7JIb2KEoYLHnOeRpSYGdP3LcQydqVhRy7-PRfxB9GjSIXliibAy808qWcwADsKNYg3KlQQn4pRvLb0qdhjtNhvI7K2-9fD8bwa1rmRgJMUIkOxjbAFeXUfUrjhfyFzDAD1Xb4fLlJ_UyXgNmF-ZmPCtpsMDaE7FD7s93Ty0I5oNLK-KOQ0RjXzUk1VzJh6dln3bfA3vphw_-flmr5DoAmXy_19t_SG6AP-5jckqHrZDF6WRmHoHPO00eWzCh5MtV49dP1Z28yg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+Variation+in+the+TP53+Pathway+and+Bladder+Cancer+Risk.+A+Comprehensive+Analysis&rft.jtitle=PloS+one&rft.au=Pineda%2C+Silvia&rft.au=Milne%2C+Roger+L.&rft.au=Calle%2C+M.+Luz&rft.au=Rothman%2C+Nathaniel&rft.date=2014-05-12&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=9&rft.issue=5&rft_id=info:doi/10.1371%2Fjournal.pone.0089952&rft_id=info%3Apmid%2F24818791&rft.externalDocID=PMC4018346 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |